Loading data
ZURANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development expense | 42.08 m USD | 24.4 m USD | 44 m USD | — |
| Operating profit | -75.25 m USD | -55.19 m USD | -62.64 m USD | -2.68 m USD |
| Profit before tax | -68.65 m USD | -52.4 m USD | -60.56 m USD | — |
| Net income (reported basis) | -68.7 m USD | -52.4 m USD | -60.36 m USD | -25.7 m USD |
| Net income attributable to common shareholders | -99.35 m USD | -45.39 m USD | -69.24 m USD | — |
| Basic earnings per share | -1.06 USD/share | -0.6 USD/share | -2.09 USD/share | — |
| Diluted earnings per share | -1.06 USD/share | -0.6 USD/share | -2.09 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.